Cabozantinib latest price in 2024

Cabozantinib is a targeted therapy used to treat certain types of cancer, particularly renal cell carcinoma (RCC) and thyroid cancer (TC). It belongs to a class of drugs called multi-target tyrosine kinase inhibitors (TKI). Its mechanism of action is to block the growth and spread of tumors by inhibiting tyrosine kinases on multiple key signaling pathways in tumor cells.

Since cabozantinib is not currently available in China, patients cannot purchase it directly domestically and must obtain it through overseas channels. Abroad, cabozantinib has two options: original drug and generic drug. The price of original research drugs is relatively high. For example, the price of original research drugs in Japan and Europe is around 30,000 to 40,000 yuan. However, there are also relatively affordable foreign generic drug options, such as generic drugs in Laos, India and Bangladesh, which cost between a few hundred to several thousand yuan, and the ingredients of these drugs are basically the same as the original drugs.

Cabozantinib may be a first-line treatment option for patients with renal cell carcinoma, especially those with advanced renal cell carcinoma that has spread to other organs or is difficult to surgically remove. The drug can inhibit tumor angiogenesis and reduce tumor blood supply. It also has anti-metastasis and anti-recurrence effects, which can prolong patient survival and alleviate symptoms.

Cabozantinib is also an effective treatment option for patients with thyroid cancer, especially those with unresectable thyroid cancer that has spread to other sites. It can inhibit the growth and spread of thyroid cancer cells, slow down the progression of the disease, and improve the survival rate of patients.

However, like other drugs, cabozantinib may also cause some side effects, including but not limited to hypertension, hand-foot syndrome, proteinuria, fatigue, dry mouth, etc. Therefore, when using this drug, doctors need to individualize treatment according to the patient's specific situation, monitor side effects and take appropriate measures.

In general, cabozantinib, as a targeted therapy, plays an important role in the treatment of renal cell carcinoma and thyroid cancer, providing patients with hope of extending survival and improving quality of life.